Clinical Trial Update: A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating ERY974 in patients with hepatocellular carcinoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ERY974

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1 | Status: ACTIVE_NOT_RECRUITING